Christopher M. Jewell, Chief Scientific Officer at Cartesian Therapeutics, Inc. (RNAC), sold 2,550 shares at $16.72 ($43K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Open-market sale of $43k RNAC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.72 | 1,264 | $21K | 49.4% |
| 2 | $16.83 | 1,286 | $22K | 50.6% |
| Total | $16.78 avg | 2,550 | $43K | 100% |